This website contains press releases and
presentations that contain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21E of the Securities Exchange Act of 1934,
as amended. These statements can be identified by the use of
forward-looking terminology, including “may,” “believe,”
“will,” “expect,” “anticipate,”
“estimate,” “plan,” “intend,”
and “forecast,” or other similar words. Such forward-looking
statements include statements concerning guidance for future
periods relating to anticipated sales, gross profit margin,
operating expenses and earnings, investments in new indication
development, net income, profits and earnings per share, maintaining
and obtaining appropriate regulatory approvals, developing VNS
as a treatment for depression and new indications, the timing
and outcome of clinical studies, improving our productivity
and efficiencies and increasing our sales, improving our net
earnings. Statements contained in this press release are based
upon information presently available to us and assumptions that
we believe to be reasonable. We are not assuming any duty to
update this information should those facts change or should
we no longer believe the assumptions to be reasonable. Our actual
results may differ materially. Important factors that may cause
actual results to differ include, but are not limited to: continued
market acceptance of VNS Therapy and sales of our product; the
development and satisfactory completion of clinical trials and/or
market test of VNS Therapy for the treatment of depression,
Alzheimer’s disease, anxiety, or other indications; adverse
changes in coverage or reimbursement amounts by third-parties;
intellectual property protection and potential infringement
claims; maintaining compliance with government regulations and
obtaining necessary government approvals for new applications;
product liability claims and potential litigation; reliance
on single suppliers and manufacturers for certain components;
the accuracy of management’s estimates of future expenses
and sales; and other risks detailed in from time to time in
the Company’s filings with the SEC.
|
 |
|
|
|
5/9/2008 |
|
|
|
|
|
|
|
4/21/2008 |
|
|
2/20/2008 |
|
|
2/6/2008 |
|
|
12/19/2007 |
|
|
12/18/2007 |
|
|
11/19/2007 |
|
|
11/8/2007 |
|
|
11/8/2007 |
|
|
9/12/2007 |
|
|
8/29/2007 |
|
|
8/22/2007 |
|
|
8/9/2007 |
|
|
8/6/2007 |
|
|
7/16/2007 |
|
|
7/9/2007 |
|
|
6/29/2007 |
|
|
6/11/2007 |
|
|
5/30/2007 |
|
|
5/7/2007 |
|
|
5/1/2007 |
|
|
5/1/2007 |
|
|
|
|
|
|
|
2/23/2007 |
|
|
2/13/2007 |
|
|
2/5/2007 |
|
|
2/1/2007 |
|
|
2/1/2007 |
|
|
1/29/2007 |
|
|
1/24/2007 |
|
|
1/23/2007 |
|
|
1/16/2007 |
|
|
1/12/2007 |
|
|
1/10/2007 |
|
|
12/29/2006 |
|
|
12/18/2006 |
|
|
11/20/2006 |
|
|
11/16/2006 |
|
|
9/27/2006 |
|
|
9/12/2006 |
|
|
9/11/2006 |
|
|
8/1/2006 |
|
|
7/21/2006 |
|
|
7/18/2006 |
|
|
7/13/2006 |
|
|
7/12/2006 |
|
|
7/11/2006 |
|
|
7/5/2006 |
|
|
6/23/2006 |
|
|
6/8/2006 |
|
|
6/6/2006 |
|
|
5/25/2006 |
|
|
5/25/2006 |
|
|
5/25/2006 |
|
|
5/24/2006 |
|
|
5/23/2006 |
|
|
5/22/2006 |
|
|
5/22/2006 |
|
|
5/22/2006 |
|
|
5/19/2006 |
|
|
5/17/2006 |
|
|
5/17/2006 |
|
|
5/1/2006 |
|
|
5/1/2006 |
|
|
|
|
|
|
|
4/28/2006 |
|
|
3/3/2006 |
|
|
2/23/2006 |
|
|
2/16/2006 |
|
|
2/8/2006 |
|
|
1/31/2006 |
|
|
1/24/2006 |
|
|
1/18/2006 |
|
|
12/1/2005 |
|
|
11/29/2005 |
|
|
11/21/2005 |
|
|
11/9/2005 |
|
|
11/3/2005 |
|
|
9/28/2005 |
|
|
9/27/2005 |
|
|
9/27/2005 |
|
|
9/26/2005 |
|
|
9/19/2005 |
|
|
9/15/2005 |
|
|
9/13/2005 |
|
|
9/8/2005 |
|
|
9/7/2005 |
|
|
8/31/2005 |
|
|
8/22/2005 |
|
|
8/18/2005 |
|
|
8/15/2005 |
|
|
7/26/2005 |
|
|
7/25/2005 |
|
|
7/19/2005 |
|
|
7/15/2005 |
|
|
6/24/2005 |
|
|
6/2/2005 |
|
|
6/1/2005 |
|
|
5/27/2005 |
|
|
5/20/2005 |
|
|
5/19/2005 |
|
|
5/18/2005 |
|
|
5/16/2005 |
|
|
5/11/2005 |
|
|
